RELIZORB is an Enzyme Replacement Therapy drug manufactured by Alcresta Therapeutics and administered via the Route Not Applicable route of administration. The B Code: B4105 is aligned to the drug RELIZORB.
RELIZORB – B4105
read more
RELIZORB is an Enzyme Replacement Therapy drug manufactured by Alcresta Therapeutics and administered via the Route Not Applicable route of administration. The B Code: B4105 is aligned to the drug RELIZORB.